Figure 4.
Non‐alcoholic fatty liver disease (NAFLD) activity scores. (a) Photomicrographs of HE‐stained liver sections in each treatment group (b) NAFLD activity scores; comparison of steatosis scores (c), ballooning (d) and inflammation scores (e). Vehicle (black), Euglena (red), paramylon (green), telmisartan (gray). n.s. indicates “not significant”